Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Type of study
Publication year range
1.
Neuroscience ; 143(2): 597-606, 2006 Dec 01.
Article in English | MEDLINE | ID: mdl-16979827

ABSTRACT

We investigated the contribution of peripheral 5-HT2A or 5-HT3 receptors to Fos expression in the trigeminal spinal nucleus (VSP) following acute masseter muscle injury in male rats with or without temporomandibular joint (TMJ) inflammation persisting for 7 days. TMJ inflammation was evoked by an injection of complete Freund's adjuvant (CFA). Two hours after formalin injection into the masseter muscle produced Fos-like immunoreactivity (Fos-LI) in several regions of the VSP and upper cervical spinal cord (C2), such as ventrolateral (vl) area of the trigeminal subnucleus caudalis (Vc)/subnucleus interpolaris (Vi) transition (vl-Vi/Vc), paratrigeminal nucleus (dPa5), middle portion of the Vc (mid-Vc) and Vc/C2 transition (Vc/C2) regions in both groups. Significant increases in the number of Fos-LI were observed in these areas in CFA group compared with non-CFA group. TMJ inflammation alone did not induce a significant level of Fos-LI in the VSP. In order to assess the effect of antagonizing 5-HT2A or 5-HT3 receptors on formalin-induced Fos-LI, rats were pre-treated with local (masseter muscle) administration of ketanserin or tropisetron (0.01, 0.1 mg/rat) 20 min prior to formalin injection. In CFA group, these antagonists given locally reduced the Fos-LI response in the laminae I-II at the mid-Vc and Vc/C2 regions. These antagonists reduced the Fos-LI response in the dPa5, but not in the vl-Vi/Vc region. The Fos-LI response was not affected by i.v. administration of ketanserin (0.01, 0.1 mg/rat) or tropisetron (0.01 mg/rat). In non-CFA group, these antagonists given locally did not reduce the Fos-LI response. These results suggest that peripheral 5-HT2A and 5-HT3 receptors contribute to nociceptive processing in the masseter muscle in TMJ inflammatory conditions.


Subject(s)
Masseter Muscle/injuries , Proto-Oncogene Proteins c-fos/metabolism , Receptor, Serotonin, 5-HT2A/physiology , Receptors, Serotonin, 5-HT3/metabolism , Temporomandibular Joint Disorders/pathology , Trigeminal Nuclei/metabolism , Animals , Disease Models, Animal , Dose-Response Relationship, Drug , Formaldehyde/pharmacology , Freund's Adjuvant/adverse effects , Functional Laterality , Gene Expression/drug effects , Gene Expression/physiology , Immunohistochemistry/methods , Indoles/pharmacology , Ketanserin/pharmacology , Male , Rats , Rats, Sprague-Dawley , Serotonin Antagonists/pharmacology , Temporomandibular Joint Disorders/complications , Temporomandibular Joint Disorders/etiology , Tropisetron
SELECTION OF CITATIONS
SEARCH DETAIL
...